Concurrent cocaine withdrawal alters alcohol withdrawal symptoms

Journal of Addictive Diseases

Volumn 21, Issue 4, 2002, Pages 13-26

  Kampman, Kyle M ^a   Pettinati, Helen ^a   Volpicelli, Joseph ^b   Kaempf, Gail ^b   Turk, Ellen ^a   Insua, Ambrose ^a   Lipkin, Craig ^a   Sparkman, Thorne ^a   O'Brien, Charles P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Affairs Medical Center   (United States)

Author keywords

Alcohol; Cocaine; Detoxification; Withdrawal

Indexed keywords

COCAINE; OXAZEPAM;

ADULT; AGE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANAMNESIS; ARTICLE; COCAINE DEPENDENCE; DETOXIFICATION; DISEASE ACTIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; OUTPATIENT CARE; SYMPTOM;

ADOLESCENT; ADULT; ALCOHOLISM; ANTI-ANXIETY AGENTS; COCAINE; COCAINE-RELATED DISORDERS; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; OXAZEPAM; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036400859     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v21n04_02     Document Type: Article

References (25)

1. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Badger GJ. Alcohol dependence and simultaneous cocaine and alcohol use in cocaine-dependent patients. J Addict Dis. 1994;13:177-189.
2. Miller NS, Millman RB, Keskinen S. Outcome at six and twelve months post inpatient treatment for cocaine and alcohol dependence. Adv Alcohol Subst Abuse. 1990;9:101-120.
3. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264:2511-2518.
4. Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment-seeking cocaine abusers: Clinical and prognostic significance. J Stud Alcohol. 1993;54:199-208.
5. Brower KJ, Blow FC, Hill EM, Mudd SA. Treatment outcome of alcoholics with and without cocaine disorders. Alcohol Clin Exp Res. 1994; 18:734-739.
6. Brady KT, Sonne S, Randall CL, Adinoff B, Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 1995;39:69-71.
7. McCance-Katz EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI. Concurrent cocaine-ethanol ingestion in humans: Pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 1993;111:39-46.
8. Farre M, de la Torre R, Gonzalez ML, Teran MT, Roset PN, Menoyo E, Cami J. Cocaine and alcohol interactions in humans: Neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther. 1997;283:164-176.
9. Hart CL, Jatlow P, Sevarino KA, McCance-Katz EF. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology (Berl). 2000;149: 153-162.
10. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry. 1986;43:107-113.
11. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. Arch Gen Psychiatry. 1990;47:861-868.
12. O'Brien CP. Drug addiction and drug abuse. In: Hardman, JG, Limbard LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996:557-577.
13. Kampman KM, Volpicelli JR, McGinnis DE, Alterman AI, Weinrieb RM, D'Angelo L, Epperson LE. Reliability and validity of the cocaine selective severity assessment. Addict Behav. 1998;23:449-461.
14. Castaneda R, Lifshulz H, Westreich L, Galanter M. Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal. Compr Psychiatry. 1995;36:441-447.
15. Gross M, Leis E, Nagareijan M. An improved quantitative system for assessing the acute psychoses and related states (TSA and SSA). In: Gross MM, ed. Alcohol Intoxication and Withdrawal Experimental Studies, Vol. 35. New York: Plenum Press, 1973.
16. Cushman P, Forbes R, Lerner W, Stewart M. Alcohol withdrawal syndromes: Clinical management with lofexidine. Alcohol Clin Exp Res. 1985;9:103-108.
17. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Subject Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
18. Stinnett JL. Outpatient detoxification of the alcoholic. Int J Add. 1982;17: 1031-1046.
19. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9:199-213.
20. Foltin RW, Fishman MW. A laboratory model of cocaine withdrawal in humans: Intravenous cocaine. Exp Clin Psychopharm. 1997;5:404-411.
21. Kuhar MJ, Pilotte NS. Neurochemical changes in cocaine withdrawal. TiPS. 1996;17:260-264.
22. Dackis CA, Gold MS. Psychopharmacology of cocaine. Psychiatr Ann. 1988; 18:528-530.
23. Koob GF, Caine SB, Parsons L, Markou A, Weiss F. Opponent process model and psychostimulant addiction. Pharm Biochem Behav. 1997;57:513-521.
24. Volkow ND, Wang G, Fowler JS, Hitzemann R, Gatley SJ, Dewey SS, Pappas N. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: A PET study. Am J Psychiatry 1998;155:200-206.
25. Schuckit MA. Alcoholism and drug dependency. In: Isselbacher KJ, Braunwald E, Wilson G, Martin JB, Fauci AS, Kasper DL,:eds. Harrison's Principles of Internal Medicine, Vol. 2. New York: McGraw-Hill, 1994:2420-2425.